Biologics
Fayetteville, US · Delaware corporation · 3 known investors
BiologicsMD is an early-stage therapeutic development company creating recombinant fusion proteins to treat hair loss diseases and conditions as well as severe bone disorders. Its treatments target disease receptors directly and are designed for sustained therapeutic exposure through single or infrequent dosing across parenteral, local, and topical delivery.
BiotechDeep TechMedical Devices
Founders & leadership
JD
J. David OwensExecutive
RG
Robyn GoforthNamed on SEC filing
RG
Rob GensureNamed on SEC filing
Board
RB
Ramsay BallBoard director
CG
Calvin GoforthBoard director
LK
Lynn KirkpatrickBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2016
▶$400KraisedFeb 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$400KraisedFeb 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ramsay BallDirector
- Robyn GoforthExecutive Officer
- Calvin GoforthDirector, Promoter
- Rob GensureExecutive Officer
- J. David OwensExecutive Officer, Director
- Lynn KirkpatrickDirector
- Offering amount
- $7M
- Amount sold
- $400K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapMacrogenics Inc6 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
Abiologics4 shared keywordsAbiologics uses computational design tools to create protein-inspired molecules called Synteins, engineered to avoid the vulnerabilities of natural protein medicines while retaining biological function. The company develops these molecules as a new class of therapeutics with the aim of advancing candidates toward clinical development.
AdvanceCT4 shared keywordsAdvanceCT is a nonprofit economic development organization that helps businesses, site selectors, and consultants evaluate and relocate to Connecticut by connecting them with data, sites, incentives, workforce information, and state and local partners. It supports companies looking to establish headquarters, facilities, or startups in the state.
Companies competing with Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Biologics do?
- BiologicsMD is an early-stage therapeutic development company creating recombinant fusion proteins to treat hair loss diseases and conditions as well as severe bone disorders. Its treatments target disease receptors directly and are designed for sustained therapeutic exposure through single or infrequent dosing across parenteral, local, and topical delivery.
- Who are Biologics's investors?
- Biologics's investors include Connecticut Innovations, Houston Angel Network, Robin Hood Ventures.
- How much funding has Biologics raised?
- Biologics has disclosed $400K raised across 1 round.
- Where is Biologics headquartered?
- Biologics is headquartered in Fayetteville, US.